S17-233 RASER – a synthetic system for targeting therapy to tumors with hyperactive signaling Researchers in Prof. Michael Lin's laboratory have developed a viral-based cancer therapy platform that could be used for targeting treatment to cancer cells with aberrant signaling in EGFR or HER2 pathways. Michael Lin Hokyung Chung